Skip to main content
Erschienen in: Clinical and Experimental Nephrology 3/2015

01.06.2015 | Original Article

Underestimating chronic kidney disease by urine dipstick without serum creatinine as a screening tool in the general Japanese population

verfasst von: Daisuke Uchida, Hiroo Kawarazaki, Yugo Shibagaki, Takashi Yasuda, Naoto Tominaga, Tsuyoshi Watanabe, Koichi Asahi, Kunitoshi Iseki, Chiho Iseki, Kazuhiko Tsuruya, Kunihiro Yamagata, Toshiki Moriyama, Ichiei Narita, Shoichi Fujimoto, Tsuneo Konta, Masahide Kondo, Masato Kasahara, Kenjiro Kimura

Erschienen in: Clinical and Experimental Nephrology | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Abstract

Background

It is not known if urine dipstick alone can identify chronic kidney disease (CKD) in the general Japanese population.

Methods

We designed a cross-sectional study using data obtained in 2008 from a nationwide community-based health examination program for adults aged 40–74. The data consisted of blood tests, urine tests and questionnaire related to metabolic disorders. Those who had both serum creatinine measured and urine dipstick tested were analyzed.

Results

Data were obtained from 538,846 people with a mean age of 62.8 years, consisting of 41.6 % males. Our study showed that 14.4 % had an eGFR below 60 mL/min/1.73 m2, 5.2 % had proteinuria and 18.1 % had CKD. Within the population with CKD, non-proteinuric CKD accounted for 71.4 %. The proportion of non-proteinuric CKD was highest in stage G3a (91.8 %) followed by G3b (77.0 %) disease, and was greater in the more elderly and in females. The proportion of non-proteinuric CKD was 47.9 % in diabetes mellitus, 69.3 % in dyslipidemia, 66.8 % in hypertension and 57.1 % in metabolic syndrome. Furthermore, non-proteinuric CKD accounted for 78.1 % of the population without these lifestyle diseases, suggesting that even in the population without apparent risk, CKD is still prevalent and can be missed when urine dipstick is the only screening method used.

Conclusions

This study showed that a considerable population of CKD might be overlooked when only dipstick proteinuria is assessed for CKD screening. Hence, we strongly recommend that both urinalysis and serum creatinine measurement should be a part of the nationwide CKD screening system.
Literatur
1.
Zurück zum Zitat Imai E, Yamagata K, Iseki K, et al. Kidney disease screening program in Japan: history, outcome, and perspectives. Clin J Am Soc Nephrol. 2007;2:1360–6.PubMedCrossRef Imai E, Yamagata K, Iseki K, et al. Kidney disease screening program in Japan: history, outcome, and perspectives. Clin J Am Soc Nephrol. 2007;2:1360–6.PubMedCrossRef
2.
Zurück zum Zitat Takeuchi H, Saitoh S, Takagi S, et al. Metabolic syndrome and cardiac disease in Japanese men: applicability of the concept of metabolic syndrome defined by the National Cholesterol Education Program-Adult Treatment Panel III to Japanese men–the Tanno and Sobetsu Study. Hypertens Res Off J Jpn Soc Hypertens. 2005;28:203–8.CrossRef Takeuchi H, Saitoh S, Takagi S, et al. Metabolic syndrome and cardiac disease in Japanese men: applicability of the concept of metabolic syndrome defined by the National Cholesterol Education Program-Adult Treatment Panel III to Japanese men–the Tanno and Sobetsu Study. Hypertens Res Off J Jpn Soc Hypertens. 2005;28:203–8.CrossRef
3.
Zurück zum Zitat Matsuzawa Y. Metabolic syndrome–definition and diagnostic criteria in Japan. J Atheroscler Thromb. 2005;12:301.PubMedCrossRef Matsuzawa Y. Metabolic syndrome–definition and diagnostic criteria in Japan. J Atheroscler Thromb. 2005;12:301.PubMedCrossRef
4.
Zurück zum Zitat Matsuo S, Imai E, Horio M, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis Off J Natl Kidney Found. 2009;53:982–92.CrossRef Matsuo S, Imai E, Horio M, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis Off J Natl Kidney Found. 2009;53:982–92.CrossRef
5.
Zurück zum Zitat Hemmelgarn BR, Manns BJ, Lloyd A, et al. Relation between kidney function, proteinuria, and adverse outcomes. JAMA J Am Med Assoc. 2010;303:423–9.CrossRef Hemmelgarn BR, Manns BJ, Lloyd A, et al. Relation between kidney function, proteinuria, and adverse outcomes. JAMA J Am Med Assoc. 2010;303:423–9.CrossRef
6.
Zurück zum Zitat Chronic Kidney Disease Prognosis Consortium, Matsushita K, van der Velde M et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010; 375:2073–2081. Chronic Kidney Disease Prognosis Consortium, Matsushita K, van der Velde M et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010; 375:2073–2081.
7.
Zurück zum Zitat Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA J Am Med Assoc. 2007;298:2038–47.CrossRef Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA J Am Med Assoc. 2007;298:2038–47.CrossRef
8.
Zurück zum Zitat Levey AS, de Jong PE, Coresh J, et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO controversies conference report. Kidney Int. 2010;80:17–28.PubMedCrossRef Levey AS, de Jong PE, Coresh J, et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO controversies conference report. Kidney Int. 2010;80:17–28.PubMedCrossRef
9.
Zurück zum Zitat Muntner P. Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease: results from the atherosclerosis risk in communities study. J Am Soc Nephrol. 2005;16:529–38.PubMedCrossRef Muntner P. Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease: results from the atherosclerosis risk in communities study. J Am Soc Nephrol. 2005;16:529–38.PubMedCrossRef
10.
Zurück zum Zitat Nakayama M, Sato T, Miyazaki M, et al. Increased risk of cardiovascular events and mortality among non-diabetic chronic kidney disease patients with hypertensive nephropathy: the Gonryo study. Hypertens Res Off J Jpn Soc Hypertens. 2011;34:1106–10.CrossRef Nakayama M, Sato T, Miyazaki M, et al. Increased risk of cardiovascular events and mortality among non-diabetic chronic kidney disease patients with hypertensive nephropathy: the Gonryo study. Hypertens Res Off J Jpn Soc Hypertens. 2011;34:1106–10.CrossRef
11.
Zurück zum Zitat Kondo M, Yamagata K, Hoshi S-L, et al. Cost-effectiveness of chronic kidney disease mass screening test in Japan. Clin Exp Nephrol. 2011;16:279–91.PubMedCentralPubMedCrossRef Kondo M, Yamagata K, Hoshi S-L, et al. Cost-effectiveness of chronic kidney disease mass screening test in Japan. Clin Exp Nephrol. 2011;16:279–91.PubMedCentralPubMedCrossRef
Metadaten
Titel
Underestimating chronic kidney disease by urine dipstick without serum creatinine as a screening tool in the general Japanese population
verfasst von
Daisuke Uchida
Hiroo Kawarazaki
Yugo Shibagaki
Takashi Yasuda
Naoto Tominaga
Tsuyoshi Watanabe
Koichi Asahi
Kunitoshi Iseki
Chiho Iseki
Kazuhiko Tsuruya
Kunihiro Yamagata
Toshiki Moriyama
Ichiei Narita
Shoichi Fujimoto
Tsuneo Konta
Masahide Kondo
Masato Kasahara
Kenjiro Kimura
Publikationsdatum
01.06.2015
Verlag
Springer Japan
Erschienen in
Clinical and Experimental Nephrology / Ausgabe 3/2015
Print ISSN: 1342-1751
Elektronische ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-014-1019-5

Weitere Artikel der Ausgabe 3/2015

Clinical and Experimental Nephrology 3/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.